Cargando…

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review

Epithelial ovarian cancer (EOC) remains the most lethal gynecological cancer in developed countries, indicating the need for further research. Although current cancer models prove useful, they have major limitations. Organoids, a novel in vitro 3D cell culture technique, derived from stem cells, cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumont, Sander, Jan, Ziga, Heremans, Ruben, Van Gorp, Toon, Vergote, Ignace, Timmerman, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839218/ https://www.ncbi.nlm.nih.gov/pubmed/31703723 http://dx.doi.org/10.1186/s13048-019-0577-2

Ejemplares similares

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
por: Maenhoudt, Nina, et al.
Publicado: (2020)

Organoids of the Female Reproductive Tract: Innovative Tools to Study Desired to Unwelcome Processes
por: Heremans, Ruben, et al.
Publicado: (2021)

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
por: Gevaert, Olivier, et al.
Publicado: (2008)

Reply: The performance of the risk of ovarian malignancy algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
por: Van Gorp, Toon, et al.
Publicado: (2012)

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Ovarian cancer and the immune system
por: Baert, Thaïs, et al.
Publicado: (2017)

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
por: De Bruyn, Christine, et al.
Publicado: (2021)

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
por: Aust, Stefanie, et al.
Publicado: (2012)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification
por: Olbrecht, Siel, et al.
Publicado: (2021)

Immunological parameters as a new lead in the diagnosis of ovarian cancer
por: Baert, T., et al.
Publicado: (2015)

Reactive Nodular Fibrous Pseudotumor: Case Report and Review of the Literature
por: Salihi, Rawand, et al.
Publicado: (2014)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
por: Watrowski, Rafał, et al.
Publicado: (2022)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

In Vitro Epithelial Organoid Generation Induced by Substrate Nanotopography
por: Shen, Yusheng, et al.
Publicado: (2015)

Organoid-derived intestinal epithelial cells are a suitable model for preclinical toxicology and pharmacokinetic studies
por: Takahashi, Yu, et al.
Publicado: (2022)

Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
por: Martinez, Alejandra, et al.
Publicado: (2020)

Mouse models of epithelial ovarian cancer for preclinical studies
por: Karakashev, Sergey, et al.
Publicado: (2021)

Prostate organoids: emerging experimental tools for translational research
por: Beshiri, Michael, et al.
Publicado: (2023)

Preclinical Modelling of PDA: Is Organoid the New Black?
por: D’Agosto, Sabrina, et al.
Publicado: (2019)

Intestinal Epithelial Organoids as Tools to Study Epigenetics in Gut Health and Disease
por: Kraiczy, Judith, et al.
Publicado: (2019)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Intrauterine Fluid Instillation and Transtubal Flow: A Randomized Controlled In vitro Trial Comparing Gel and Water
por: Thijssen, Soetkin G., et al.
Publicado: (2019)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

An Organoid-Based Preclinical Model of Human Gastric Cancer
por: Steele, Nina G., et al.
Publicado: (2018)

Cardiac organoid — a promising perspective of preclinical model
por: Zhao, Dandan, et al.
Publicado: (2021)

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
por: Baert, Thaïs, et al.
Publicado: (2015)

Lung organoids, useful tools for investigating epithelial repair after lung injury
por: Kong, Jing, et al.
Publicado: (2021)

Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
por: Gorski, Justin W., et al.
Publicado: (2021)

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
por: Chan, Wai Sun, et al.
Publicado: (2023)

Organoids: An Emerging Tool to Study Aging Signature across Human Tissues. Modeling Aging with Patient-Derived Organoids
por: Torrens-Mas, Margalida, et al.
Publicado: (2021)

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium
por: Braicu, Elena Ioana, et al.
Publicado: (2014)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fjrglm5qrcr9msl05ggo491tuo